Corresponding Author: Eileen S. Hwang, MD, PhD, Department of Ophthalmology and Visual Sciences, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 (eileenhwang@yahoo.com).
Published Online: January 6, 2022. doi:10.1001/jamaophthalmol.2021.3326
Conflict of Interest Disclosures: Dr Hwang reports nonfinancial support from Regeneron, Beaver Vistec, Katalys, Alcon, and Bausch & Lomb. Dr Kim reports personal fees from Allergan, Adverum, Astellas, Genentech, Novartis, and Regeneron and research support from Heidelberg, Notal Vision, and Optos. No other disclosures were reported.
Meeting Presentation: This work was presented by Dr Kim at the Hawaiian Eye/Retina Meeting; January 13, 2018; Kihei, Hawaii.
Additional Contributions: We thank Marriner Altmann, CRA, OCT-C, CPT, Medical College of Wisconsin/Froedtert Eye Institute, for obtaining the images. She did not receive compensation.
3.Sawada
Y , Hangai
M , Murata
K , Ishikawa
M , Yoshitomi
T . Lamina cribrosa depth variation measured by spectral-domain optical coherence tomography within and between four glaucomatous optic disc phenotypes.
Invest Ophthalmol Vis Sci. 2015;56(10):5777-5784. doi:
10.1167/iovs.14-15942PubMedGoogle ScholarCrossref 6.Hazlewood
RJ , Roos
BR , Solivan-Timpe
F ,
et al. Heterozygous triplication of upstream regulatory sequences leads to dysregulation of matrix metalloproteinase 19 in patients with cavitary optic disc anomaly.
Hum Mutat. 2015;36(3):369-378. doi:
10.1002/humu.22754PubMedGoogle ScholarCrossref 7.Hwang
ES , Morgan
DJ , Pennington
KL ,
et al. Progressive optic nerve changes in cavitary optic disc anomaly: integration of copy number alteration and cis-expression quantitative trait loci to assess disease etiology.
BMC Med Genet. 2019;20(1):63. doi:
10.1186/s12881-019-0800-4PubMedGoogle ScholarCrossref